本文へ移動
cccskills
無料GitHub で公開

jes-pa-avs-acth-stimulation

Recommends ACTH stimulation during AVS to improve success rate of bilateral selective catheterization, acknowledging unclear impact on diagnostic accuracy for laterality. Triggers include when setting up AVS and asking 'Should I administer ACTH?' or considering procedural optimization.

インストール方法を見る

含まれるファイル(1)

  • SKILL.md2.1 KB

SKILL.md(原文)

インストールする前に、エージェントに与えられる指示の中身を確認できます。

Determine whether to use ACTH stimulation during adrenal venous sampling

STEP 1 — Gather Information

Collect patient eligibility for AVS (positive confirmatory test for PA, surgical intent), availability of synthetic ACTH (Cosyntropin), planned AVS protocol (IV bolus vs infusion), timing of blood sampling relative to ACTH, and institutional AVS expertise; then determine if AVS is indicated.

STEP 2 — Rule In / Rule Out

Is adrenal venous sampling (AVS) indicated for subtype diagnosis in primary aldosteronism? If no, do not proceed with ACTH stimulation. If yes, proceed to evaluate ACTH use.

STEP 3 — Classify or Stratify

Classify the goal: If aiming to improve success rate of bilateral selective catheterization during AVS, proceed to recommend ACTH stimulation; if focusing solely on diagnostic accuracy for laterality, note ACTH stimulation’s unclear impact.

STEP 4 — Decide

Recommend administering ACTH stimulation during AVS to increase the selectivity index and achieve successful bilateral selective catheterization.

Clinical Guardrails / Mimics / Pitfalls

ACTH stimulation does not reliably improve diagnostic accuracy for laterality; ensure ACTH‑sampling interval of 15–30 min; avoid use in rare ACTH hypersensitivity; do not substitute ACTH for proper catheter technique or center expertise; consider institutional protocols for ACTH dosing (IV bolus 250 μg or infusion 50–80 μg/h).

Concrete Clinical Example

A 48‑year‑man with PA undergoes AVS at an experienced center; after 250 μg IV ACTH bolus, bilateral selective catheterization achieved (SI ≥ 5), enabling subtype diagnosis and guiding adrenalectomy.

Source: Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021, Japan Endocrine Society, 2021

レビュー

まだレビューはありません。使ってみた感想をお寄せください。

同じリポジトリのスキル

概要と使いどころ

Guide pump setting adjustments for the MiniMed 780G system based on CareLink data, using Medtronic's 3-step follow-up workflow. Use when a clinician has CareLink data for a 780G patient and wants to know what to change — which setting, by how much, and how to program it. Triggers include: "what do I adjust", "how to fix high TIR", "how to reduce hypos", "adjust ICR/ISF/basal", "SmartGuard settings", "780G pump settings review", or any question about optimising 780G therapy after reviewing a download.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Performs corticotropin stimulation test to diagnose adrenal insufficiency when morning cortisol is indeterminate (3-15 µg/dL). Triggers include morning cortisol 3-15 µg/dL requiring further AI testing.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Administers immediate parenteral injection of 50–100 mg hydrocortisone for suspected adrenal crisis secondary to adrenal insufficiency. Triggers include hypotension, hypoglycemia, or acute illness in a patient with known adrenal insufficiency.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Clinicians educate adrenal insufficiency patients taking nondexamethasone glucocorticoids who initiate enzyme-inducing antiepileptic drugs about early signs of adrenal insufficiency. Trigger when an AI patient on nondexamethasone GC starts an enzyme-inducing AED such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

In central hypothyroidism patients receiving levothyroxine who initiate enzyme‑inducing antiepileptic drugs, the guideline recommends checking free T4 at least 6 weeks after AED start and increasing the levothyroxine dose if free T4 falls below the target range. Triggers include: central hypothyroidism patient on levothyroxine starting antiepileptic drug such as phenytoin, carbamazepine, or oxcarbazepine.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

Applies serum cortisol cutoffs (<3 μg/dL indicates central adrenal insufficiency; >15 μg/dL likely excludes it) when evaluating morning cortisol for suspected adrenal insufficiency. Triggers include morning cortisol measurement in suspected AI and use when interpreting morning cortisol levels for adrenal insufficiency workup.

日本語の概要は準備中です。原文の説明を表示しています。

dromlakhani/MD2SKILL132026年10月5日 更新

dromlakhani のスキルをすべて見る

このスキルの問題を報告する